A Pfizer vaccine to protect older adults and infants from respiratory syncytial virus (RSV) infection has shown what some scientists are calling "exciting" promise in late-stage trials.
Exciting promise for RSV vaccine – Caribbean Broadcasting Corporation cbc.bb - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbc.bb Daily Mail and Mail on Sunday newspapers.
Late-stage RSV vaccine trials show exciting promise, some scientists say localnews8.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from localnews8.com Daily Mail and Mail on Sunday newspapers.
A Pfizer vaccine to protect older adults and infants from respiratory syncytial virus (RSV) infection has shown what some scientists are calling "exciting" promise in late-stage trials.
A Pfizer vaccine to protect older adults and infants from respiratory syncytial virus (RSV) infection has shown what some scientists are calling "exciting" promise in late-stage trials.